News & Updates

Cancer patients who experience treatment delays due to the COVID-19 pandemic restrictions may be vulnerable to psychological distress, reports a recent China study. Effective communication from doctors and other cancer care professionals may help mitigate this effect.

Device-guided breathing (DGB), as facilitated by the RESPeRATE device, appears to reduce test anxiety and can boost subsequent test performance among students, according to a recent study.

Internet searches related to depression or anxiety appear to be correlated with the population-wide burden of these mental health conditions, reports a recent US study.

Several studies presented at ACOG 2022 have raised the question as to whether postpartum depression (PPD) is one of the mental health outcomes of the COVID-19 pandemic.

Electroconvulsive therapy (ECT) or the delivery of a finely controlled electric current to the brain in patients with schizophrenia can effectively address negative symptoms, which in turn translates to improvements in overall function, as shown in a study from Singapore.

Among individuals who have undergone repeated assessments for depression, the presence of high symptoms at multiple timepoints raises the risk of developing stroke, according to a study.

People who experienced symptomatic COVID-19 are more likely to suffer from feelings of nervousness, anxiousness, and tension than those who had oligosymptomatic disease, a recent study has found. Such an effect appears to be pronounced in women and younger survivors.

Among older Southeast Asian type 2 diabetes mellitus patients, severe hypoglycaemia tends to occur with tighter glycaemic control, greater impaired hypoglycaemia awareness, and higher worry scores, regardless of treatment regimens, according to a study.